Richard Wagner
Directeur Général chez Bonito Biosciences
Fortune : - $ au 31/05/2024
Profil
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts) founded in 2009, Zebiai Therapeutics, Inc. founded in 2019, and Bonito Biosciences founded in 2022, where he held the title of Chief Executive Officer.
He also held the position of Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. and served as an Independent Director at Eterna Therapeutics, Inc. for the year 2023.
Dr. Wagner holds a doctorate degree from Brown University and an undergraduate degree from Trinity College (Connecticut).
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ETERNA THERAPEUTICS INC.
-.--% | 13/07/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Richard Wagner
Sociétés | Poste | Début |
---|---|---|
Bonito Biosciences | Directeur Général | 01/06/2022 |
Anciens postes connus de Richard Wagner
Sociétés | Poste | Fin |
---|---|---|
ETERNA THERAPEUTICS INC. | Directeur/Membre du Conseil | 08/08/2023 |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Directeur Général | 03/06/2020 |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Directeur Général | - |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Richard Wagner
Brown University | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ETERNA THERAPEUTICS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
Bonito Biosciences | |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |